CXCL12 and breast carcinoma: In addition, cats with CXCR4-positive mammary carcinomas showed lower serum SDF-1 levels then cats with CXCR4-negative mammary carcinomas (p=0.027), uncovering a putative negative feedback of the SDF-1 ligand on SDF-1/CXCR4 axis.